Holding 50,000 IRR bn capital, Isfahan Steel Company recognized only 489 IRR EPS for the FY2014 while this amount was 858 IRR EPS for the FY2013 with 36,000 IRR bn capital. Considering the new capital, however, the company’s EPS would be 617 IRR. As a result, the real earning in the FY2014 is 21% less than the last year. Although the company’s net profit reached 101,999 IRR bn by a 5% increase, its 24% increased final cost ended in the 21% fall of the gross profit. Besides, the sum of its expenses in the FY2014 decreased by 238% and the operating profit also faced a 31% fall; on the other hand, its financial costs climbed up by 25%. Totally speaking, Esfahan Steel Company started its long term descending trend since winter 2013 and despite some surges, it has failed to break this downward trend. Therefore, experts assume that this company is approaching its loss limit.
IRCA Part Sanat Manufacturing Company released its audited performance report for the FY2014 ending March 20, 2015. Owning 85 IRR bn capital, this company recognized 1,233 IRR EPS which was accompanied by a 148% growth compared to the last year. The statistics show that its net sales moved beyond 410 IRR bn with an 80% growth; the final cost jumped up by 74% and 141.7 IRR bn gross profit was made being 91% more than the previous year. The sum of its expenses increased by 36%; however, the financial costs were reduced by 45% and its operating profit reached 110.6 IRR bn by a 116% increase.
Chin Chin Agro-Industries Co. released its first audited budget for the FY2016 ending June 20, 2016. With its 100 IRR bn capital, this company has forecasted its EPS to be 558 IRR; this amount is 412 IRR for the FY2015. In its budget for the FY2016, the company’s net sales and servicing income has been estimated to be 274 IRR bn which shows a 142% growth compared to the last year. Its gross profit has also been forecasted to be 88.6 IRR bn demonstrating a 23% raise. Besides, if realized, its operating profit has been predicted to be 94.7 IRR bn which will be accompanied by a 17% growth and its financial costs are estimated to be 20.1 IRR bn.
TSE at a Glance
IFB at a Glance
Trading Halts & Delays
The market is still under the full influence of nuclear talks and the more we approach the deadline, the more sectors such as baking, transportation, and leasing will experience a positive trend. Taking the market atmosphere during the previous negotiations into account, we expect the market to reach a 10-15% growth; however, in case of any extension, prices may fall to the previous floor prices. Therefore, we still insist that investing in such an unstable market is merely suggested to risk takers. It is worthy to say that regardless of the negotiations results, even risk averse investors can be advised to buy pharmaceutical shares due to their low risk nature and high sales ratio.
DISCLAIMER: This report has been prepared and issued by Agah Brokerage Firm on the basis of publicly available information, internally developed data and other sources believed to be reliable. The information contained herein is not guaranteed, does not purport to be comprehensive and is strictly for information purposes only. Agah does not assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions. Any expressions of opinions are subject to change without notice.
To contact the reporters: Negar Moshirfatemi at firstname.lastname@example.org